Development of eczema vaccinatum in atopic mouse models and efficacy of MVA vaccination against lethal poxviral infection.

by Jarmila Knitlova, Vera Hajkova, Ludek Voska, Jana Elsterova, Barbora Obrova, Zora Melkova
Published 2014-01-01

O3 Heme-arginate as a latency-reversing agent for HIV-1 cure

by Michaela Madlenakova, Prakash Shankaran, Vera Hajkova, David Jilich, Ladislav Machala, Pavel Martasek, Zora Melkova
Published 2017-09-01

Expression of TIM-3 on Plasmacytoid Dendritic Cells as a Predictive Biomarker of Decline in HIV-1 RNA Level during ART

by Albert Font-Haro, Vaclav Janovec, Tomas Hofman, Ladislav Machala, David Jilich, Zora Melkova, Jan Weber, Katerina Trejbalova, Ivan Hirsch
Published 2018-03-01

P1 Protein expression from unintegrated HIV-1 DNA introduces bias in primary in vitro latency models

by Pawel Bonczkowski, Marie-Angélique De Scheerder, Eva Malatinkova, Alexandra Borch, Zora Melkova, Renate Koenig, Ward De Spiegelaere, Linos Vandekerckhove
Published 2016-09-01